ANDA 90986, held by Wockhardt USA. Octreotide Acetate.
As of Nov 16, 2026, ANDA 90986 (Octreotide Acetate), held by Wockhardt USA, was first approved by FDA on May 11, 2011, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 11, 2011 | Original application | Approved | None posted |
| Octreotide AcetateEQ 0.2MG BASE/ML · injectable;injection | Octreotide Acetate | Discontinued |
| Octreotide AcetateEQ 1MG BASE/ML · injectable;injection | Octreotide Acetate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters